MetaVia Inc. – Filings and Transcripts

NASDAQ: MTVA
Share price (6/2/26): $2.71
Market cap (6/2/26): $14.0 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Prospectus supplement

Registration of securities for employees

Updated info for already-effective prospectus

Prospectus supplement with pricing info

Addition of securities to prior initial registration

Ownership Filter

Alyeska Investment Group, L.P.

Woodworth Marshall H

Armistice Capital, LLC

Woodworth Marshall H

News Filter

Presents Higher-Dose Phase 1 Results for DA-1726 at EASL Congress 2026, Supporting Potential in Obesity and MASH

To Present Obesity Data at the American Diabetes Association's (ADA) 2026 Scientific Sessions

Reports First Quarter 2026 Financial Results and Provides Corporate Update

To Present Data Highlighting DA-1726, a GLP-1/Glucagon Dual Agonist, in a Late-Breaking Poster Presentation at the EASL Congress 2026

Doses the First Patient in Higher-Dose Phase 1 Study of DA-1726, Its GLP-1 and Glucagon Dual Agonist for the Treatment of Obesity

Proxies Filter

Definitive proxy

Preliminary proxy

Definitive proxy

Preliminary proxy

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC